Results 31 to 40 of about 101 (77)
Fungal diagnostics and antifungal drug access in Latin America and the Caribbean: an ESCMID EFISG multinational survey. [PDF]
Nat CommunPasqualotto AC, Berrio I, Ortiz B, Maquera-Afaray J, Fernández N, Varela D, Cuéllar LE, Pérez F, Perurena Lancha MR, Perales D, Dolande M, Bonifaz A, Ceballos A, Magalhães TCO, Cornely OA, Falci DR, Salmanton-García J. +16 moreeuropepmc +1 more sourceThree-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. [PDF]
OncologistGarcía-Alfonso P, Jimenez-Fonseca P, Soto-Alsar J, Baraibar I, Santos C, La Casta A, Ghanem I, Pulido Cortijo G, Mariño Méndez A, Pazo-Cid R, Vera R, Melián M, Alcaide J, Graña B, Páez D, Gallego I, Lobo M, Borregón M, Fernández Montes A, Martínez de Castro E, Carmona-Bayonas A, Aranda E. +21 moreeuropepmc +1 more sourceTen-Year Outcomes in Colorectal Cancer-Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study. [PDF]
J Clin MedGarcía-Aranda M, Martín-García D, Gallejones-Eskubi J, Urrechaga E, Ferreiro J, Portugal V, Portillo I, Jiménez-Toscano M, Legarreta MJ, Quintana JM, Redondo M, Aguirre U, REDISSEC/CARESS-CCR Group. +12 moreeuropepmc +1 more sourcePrediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study. [PDF]
J Clin Oncol, 2019 Carmona-Bayonas A, Jiménez-Fonseca P, Lamarca Á, Barriuso J, Castaño Á, Benavent M, Alonso V, Riesco-Martínez MDC, Alonso-Gordoa T, Custodio A, Sánchez Cánovas M, Hernando Cubero J, López C, Lacasta A, Fernández Montes A, Marazuela M, Crespo G, Escudero P, Diaz JÁ, Feliciangeli E, Gallego J, Llanos M, Segura Á, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle JW, García-Carbonero R. +28 moreeuropepmc +1 more sourceImpact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer. [PDF]
BMC Cancer, 2019 Sarasqueta C, Perales A, Escobar A, Baré M, Redondo M, Fernández de Larrea N, Briones E, Piera JM, Zunzunegui MV, Quintana JM, REDISECC-CARESS/CCR group. +10 moreeuropepmc +1 more sourceImpact of errors of creatinine and cystatin C equations in the selection of living kidney donors. [PDF]
Clin Kidney J, 2019 González-Rinne A, Luis-Lima S, Escamilla B, Negrín-Mena N, Ramírez A, Morales A, Vega N, García P, Cabello E, Marrero-Miranda D, Aldea-Perona A, Alvarez A, Abad MDC, Pérez-Tamajón L, González-Rinne F, González-Delgado A, Díaz Martín L, Jiménez-Sosa A, Torres A, Porrini E. +19 moreeuropepmc +1 more sourceColorectal cancer health services research study protocol: the CCR-CARESS observational prospective cohort project. [PDF]
BMC Cancer, 2016 Quintana JM, Gonzalez N, Anton-Ladislao A, Redondo M, Bare M, Fernandez de Larrea N, Briones E, Escobar A, Sarasqueta C, Garcia-Gutierrez S, Aguirre U, REDISSEC-CARESS/CCR group. +11 moreeuropepmc +1 more sourcePrognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study. [PDF]
BMC Cancer, 2018 Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A. +25 moreeuropepmc +1 more source